A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Data Set Name | Responsible WG | Expected Availability as of October | Comment as of October | Status | Comments | ||||||||||||||||||
2 | ||||||||||||||||||||||||
3 | Basic Information | |||||||||||||||||||||||
4 | Excluded/Included/Graylist | PCAWG-Tech | AVAILABLE | AVAILABLE | ||||||||||||||||||||
5 | Donor clinical data | PCAWG-10/13 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
6 | Specimen histopathological data | PCAWG-10/13 | AVAILABLE | AVAILABLE | Clinical sex updated in mid Nov: 8 previously missing have been filled, 2 revised | |||||||||||||||||||
7 | Specimen QC (stars) | PCAWG-QC | AVAILABLE | AVAILABLE | Complete and Final (not changed since 2016/06/01) | |||||||||||||||||||
8 | WGS alignments | PCAWG-Tech | AVAILABLE | AVAILABLE | ||||||||||||||||||||
9 | RNAseq alignments | PCAWG-3 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
10 | ID Mapping for miRNA specimens | PCAWG-Tech | ADD methylation & miRNA specimens | AVAILABLE | Mapping to be posted | |||||||||||||||||||
11 | ID Mapping for methylation specimens | PCAWG-Tech | TBD | Pending completion of methylation analysis by PCAWG-4 | ||||||||||||||||||||
12 | ||||||||||||||||||||||||
13 | Variant Calls | |||||||||||||||||||||||
14 | SNV & Indel calls from 3 core pipelines | PCAWG-Tech | AVAILABLE | AVAILABLE | ||||||||||||||||||||
15 | Merged SNVs and indels | PCAWG-1 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
16 | Merged SVs | PCAWG-6 | AVAILABLE | retrotransposons are removed | AVAILABLE | Revised in mid Nov to remove additional artifacts; low impact | ||||||||||||||||||
17 | Merged CNAs | PCAWG-11 | End of October (Clonal) | Subclonal copy number estimates end of November (pcawg-11) | AVAILABLE | |||||||||||||||||||
18 | Germline SNP calls | PCAWG-8 | Early November | including phasing | Early April | Recommend to use Broad/HaplotypeCaller germline callset interim; repeat analyses when integrated haplotype-phased callset becomes available | Latest update from Jan Korbel 20 February 2017 | |||||||||||||||||
19 | Germline CNVs | PCAWG-8 | AVAILABLE | Deletions only | AVAILABLE | Deletions only | ||||||||||||||||||
20 | Cell Line SNVs and Indels | PCAWG-Tech | End of October | AVAILABLE | Pending filtering and consensus merge | |||||||||||||||||||
21 | ||||||||||||||||||||||||
22 | Methylation | |||||||||||||||||||||||
23 | 450k Array | PCAWG-4 | mid November | AVAILABLE | RnB normalized data uploaded to sftp site: /pancan/pcanwg4/450KData_normalized | |||||||||||||||||||
24 | Bisulfite modified sites | PCAWG-4 | mid November | AVAILABLE | Data uploaded to sftp site: /pancan/pcanwg4/WGBS | |||||||||||||||||||
25 | Differentially-methylated regions | PCAWG-4 | f/u needed | AVAILABLE | Data uploaded to sftp site: /pancan/pcanwg4/WGBS_ICGC_Data & WGBS_ICGC_FL_Data | |||||||||||||||||||
26 | ||||||||||||||||||||||||
27 | RNA/Expression Calls | |||||||||||||||||||||||
28 | mRNA expression levels | PCAWG-3 | AVAILABLE | AVAILABLE | Updated on Nov. 22 | |||||||||||||||||||
29 | miRNA expression | PCAWG-14 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
30 | lincRNA expression | PCAWG-14 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
31 | ||||||||||||||||||||||||
32 | Reference Annotations | |||||||||||||||||||||||
33 | Standard colors and terminology | PCAWG-10/13 | AVAILABLE | R library pending | AVAILABLE | |||||||||||||||||||
34 | References genes & elements | Ekta Khurana | AVAILABLE | Needs to be added to Data Set Page | AVAILABLE | |||||||||||||||||||
35 | Pathogen validation set | PCAWG-16 | AVAILABLE | Needs to be added to Data Set Page | AVAILABLE | Needs to be added to Data Set Page | ||||||||||||||||||
36 | Gene sets and pathways | PCAWG-5 | AVAILABLE | Needs to be added to Data Set Page | AVAILABLE | Needs to be added to Data Set Page | ||||||||||||||||||
37 | ||||||||||||||||||||||||
38 | Drivers | |||||||||||||||||||||||
39 | Coding driver element catalogue | PCAWG-9 | mid-November | AVAILABLE | Released April 21 | |||||||||||||||||||
40 | Non-coding driver element catalogue | PCAWG-2 | mid-November | AVAILABLE | Released April 21 | |||||||||||||||||||
41 | ncRNA driver catalogue | PCAWG-14 | mid-November | AVAILABLE | Released April 21 | |||||||||||||||||||
42 | SV driver events | PCAWG-6 | mid-November | AVAILABLE | Released April 21 | |||||||||||||||||||
43 | CNA driver events | PCAWG-6 | mid-November | Clonal events earlier | AVAILABLE | Released April 21 | ||||||||||||||||||
44 | Germline driver variants | PCAWG-8 | mid-November | AVAILABLE | Released April 21 | |||||||||||||||||||
45 | Sigificantly mutated genes | PCAWG-9 | AVAILABLE | Coding driver genes per tumor type based on previous knowledge | AVAILABLE | Coding driver genes per tumor type based on previous knowledge | ||||||||||||||||||
46 | Patient-centric driver catalogue - Noncoding | PCAWG-9 | mid-November | conservative; TERT only | April 28 | Pending driver catalogue completion | ||||||||||||||||||
47 | Patient-centric driver catalogue - Coding | PCAWG-9 | AVAILABLE | conservative | AVAILABLE | conservative | ||||||||||||||||||
48 | ||||||||||||||||||||||||
49 | Expression | |||||||||||||||||||||||
50 | eQTLs | PCAWG-3 | Delayed | Reproducibility issues | AVAILABLE | Final call sets based on Broad GATK germline calls depend on final germline set | ||||||||||||||||||
51 | Allele-specific expression | PCAWG-3 | end of November | ? | Depends on consensus CNV | |||||||||||||||||||
52 | mRNA splicing | PCAWG-3 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
53 | Fusion transcripts | PCAWG-3 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
54 | Alternative promoter usage | PCAWG-3 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
55 | RNA Editing | PCAWG-3 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
56 | ||||||||||||||||||||||||
57 | ||||||||||||||||||||||||
58 | Subclones & evolution | |||||||||||||||||||||||
59 | Purity & ploidy | PCAWG-11 | mid-November | AVAILABLE | Final ploidy available; purity of copy number quiet cases will be patched | |||||||||||||||||||
60 | Per-variant clonality/timing status | PCAWG-11 | mid-December | AVAILABLE | "Beta 1" | |||||||||||||||||||
61 | Per-variant cancer cell fraction | PCAWG-11 | end of November | AVAILABLE | "Beta 1" | |||||||||||||||||||
62 | ||||||||||||||||||||||||
63 | Signatures | |||||||||||||||||||||||
64 | Conservative Mutational Signature Catalogue | PCAWG-7 | end of October | f/u needed | AVAILABLE | 2 March - going up on Synapse; available via DropBox | ||||||||||||||||||
65 | Per-sample signature composition | PCAWG-7 | end of October | f/u needed | AVAILABLE | 2 March - going up on Synapse; available via DropBox | ||||||||||||||||||
66 | Per-mutation signature attribution | PCAWG-7 | end of October | f/u needed | ? | Last update from Mike Stratton 1 March | ||||||||||||||||||
67 | ||||||||||||||||||||||||
68 | Others | |||||||||||||||||||||||
69 | Significantly mutated pathways | PCAWG-5 | f/u needed | ? | f/u needed | |||||||||||||||||||
70 | Pathogen predictions | PCAWG-16 | beginning of December | mid December | ||||||||||||||||||||
71 | HLA & KIR haplotyping | PCAWG-15 | AVAILABLE | AVAILABLE | ||||||||||||||||||||
72 | Neo-antigen predictions | PCAWG-15 | end of October | f/u needed | AVAILABLE | |||||||||||||||||||
73 | MSI predictions | PCAWG-7 | end of October | f/u needed | AVAILABLE | |||||||||||||||||||
74 | Molecular subtypes | many groups | ? | |||||||||||||||||||||
75 | APOBEC mutagenesis | PCAWG-7 | AVAILABLE | on Synapse; November 8, 2016 | ||||||||||||||||||||
76 | ||||||||||||||||||||||||
77 | ||||||||||||||||||||||||
78 | ||||||||||||||||||||||||
79 | ||||||||||||||||||||||||
80 | ||||||||||||||||||||||||
81 | ||||||||||||||||||||||||
82 | ||||||||||||||||||||||||
83 | ||||||||||||||||||||||||
84 | ||||||||||||||||||||||||
85 | ||||||||||||||||||||||||
86 | ||||||||||||||||||||||||
87 | ||||||||||||||||||||||||
88 | ||||||||||||||||||||||||
89 | ||||||||||||||||||||||||
90 | ||||||||||||||||||||||||
91 | ||||||||||||||||||||||||
92 | ||||||||||||||||||||||||
93 | ||||||||||||||||||||||||
94 | ||||||||||||||||||||||||
95 | ||||||||||||||||||||||||
96 | ||||||||||||||||||||||||
97 | ||||||||||||||||||||||||
98 | ||||||||||||||||||||||||
99 | ||||||||||||||||||||||||
100 |